Toll Brothers, Inc. (TOL)

Orchard Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	12,596	14,786	7,600	4,882	7,324	5,335
Market Cap Growth	-19.16%	94.56%	55.66%	-33.34%	37.28%	-4.47%
Enterprise Value	14,839	16,859	9,558	8,018	10,132	8,817
Last Close Price	128.29	145.48	69.73	41.93	57.67	40.06
PE Ratio	9.50	9.41	5.54	3.80	8.79	11.95
Forward PE	9.28	10.20	6.03	4.50	7.24	10.53
PS Ratio	1.22	1.36	0.76	0.48	0.83	0.75
PB Ratio	1.59	1.92	1.12	0.81	1.37	1.08
P/TBV Ratio	1.58	1.93	1.12	0.81	1.38	1.09
P/FCF Ratio	17.41	15.79	6.37	5.34	5.92	5.94
P/OCF Ratio	15.74	14.64	6.00	4.95	5.62	5.29
PEG Ratio	1.87	1.04	1.03	0.90	0.22	1.15
EV/Sales Ratio	1.39	1.55	0.96	0.78	1.15	1.25
EV/EBITDA Ratio	7.72	7.72	5.13	4.93	9.00	13.03
EV/EBIT Ratio	8.07	8.01	5.35	5.17	9.66	14.51
EV/FCF Ratio	20.51	18.00	8.01	8.76	8.20	9.81
Debt / Equity Ratio	0.37	0.39	0.44	0.58	0.69	0.83
Debt / EBITDA Ratio	1.51	1.34	1.58	2.10	3.21	5.82
Debt / FCF Ratio	4.05	3.16	2.50	3.79	2.98	4.54
Asset Turnover	0.78	0.84	0.81	0.86	0.78	0.65
Inventory Turnover	0.75	0.83	0.82	0.93	0.88	0.72
Quick Ratio	0.27	0.63	0.68	0.57	0.66	0.79
Current Ratio	3.99	5.03	5.08	4.20	3.82	4.86
Return on Equity (ROE)	18.05%	21.67%	21.38%	22.64%	16.24%	8.89%
Return on Assets (ROA)	8.37%	10.15%	9.00%	8.13%	5.80%	3.47%
Return on Capital (ROIC)	10.85%	12.86%	11.58%	10.47%	7.27%	4.21%
Return on Capital Employed (ROCE)	16.50%	19.00%	17.20%	15.90%	11.80%	6.70%
Earnings Yield	10.96%	10.63%	18.05%	26.35%	11.38%	8.37%
FCF Yield	5.74%	6.33%	15.70%	18.74%	16.88%	16.84%
Dividend Yield	0.78%	0.62%	1.19%	1.84%	1.07%	1.10%
Payout Ratio	7.11%	5.95%	6.64%	6.91%	9.19%	12.67%
Buyback Yield / Dilution	5.21%	5.69%	5.91%	6.22%	4.15%	10.41%
Total Shareholder Return	6.01%	6.31%	7.09%	8.06%	5.22%	11.51%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q